Sean Janzer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sean janzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sean Janzer Today - Breaking & Trending Today
Avinger, Inc.: Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Avinger, Inc.: Avinger Tigereye CTO Crossing Featured in Live Case at LINC 2021 REDWOOD CITY, CA / ACCESSWIRE / February 3, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that its Tigereye CTO crossing system and Pantheris atherectomy system were featured in a live case transmission on January 29 at the Leipzig Interventional Course (LINC) 2021. LINC is a leading global forum for new methods and technology in the field of vascular medicine held each year in Leipzig, Germany. Dr. Arne Schwindt, a vascular surgeon at St. Franziskus Hospital in Münster, Germany and a pioneer in the OCT-guided treatment of vascular disease, performed the live endovascular procedure using Tigereye during a session entitled, CTO-Crossing with New OCT-Image Guided and Steerable Catheter. The patient, a 57-y ....
Press release content from Accesswire. The AP news staff was not involved in its creation. Avinger Tigereye CTO Crossing Featured in Live Case at LINC 2021 February 3, 2021 GMT REDWOOD CITY, CA / ACCESSWIRE / February 3, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that its Tigereye™ CTO crossing system and Pantheris atherectomy system were featured in a live case transmission on January 29 at the Leipzig Interventional Course (LINC) 2021. LINC is a leading global forum for new methods and technology in the field of vascular medicine held each year in Leipzig, Germany. ....